A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. - Wikidata - wikimedia - TriplyDB

A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.

A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.

http://www.wikidata.org/entity/Q35052559

about

Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3 TIP48/Reptin and H2A.Z requirement for initiating chromatin remodeling in estrogen-activated transcription FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis Pioneer transcription factors: establishing competence for gene expression Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers Differential estradiol and selective estrogen receptor modulator (SERM) regulation of Keratin 13 gene expression and its underlying mechanism in breast cancer cells FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription A FOXA1-binding enhancer regulates Hoxb13 expression in the prostate gland Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc Histone deacetylase 7 and FoxA1 in estrogen-mediated repression of RPRM Chromatin architecture defines the glucocorticoid response Cooperating transcription factors mediate the function of estrogen receptor Ligand-binding dynamics rewire cellular signaling via estrogen receptor-α Targeting NF-kappaB in Waldenstrom macroglobulinemia Cyclin D1 determines estrogen signaling in the mammary gland in vivo Genome-wide location analysis reveals distinct transcriptional circuitry by paralogous regulators Foxa1 and Foxa2 Gain- and Loss-of-Function Mutations in the Breast Cancer Gene GATA3 Result in Differential Drug Sensitivity Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer.Multivariate gene expression analysis reveals functional connectivity changes between normal/tumoral prostates Genome-wide mechanisms of nuclear receptor action.Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha.HEXIM1 regulates 17beta-estradiol/estrogen receptor-alpha-mediated expression of cyclin D1 in mammary cells via modulation of P-TEFb Is there an association between enhanced choline and β-catenin pathway in breast cancer? A pilot study by MR Spectroscopy and ELISA.Anacardic acid inhibits estrogen receptor alpha-DNA binding and reduces target gene transcription and breast cancer cell proliferation.Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer.Modulation of androgen receptor by FOXA1 and FOXO1 factors in prostate cancer.Unraveling the regulatory connections between two controllers of breast cancer cell fate An integrated pipeline for the genome-wide analysis of transcription factor binding sites from ChIP-Seq.Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha.Estrogen receptor alpha 46 is reduced in tamoxifen resistant breast cancer cells and re-expression inhibits cell proliferation and estrogen receptor alpha 66-regulated target gene transcription.Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells Study of FoxA pioneer factor at silent genes reveals Rfx-repressed enhancer at Cdx2 and a potential indicator of esophageal adenocarcinoma development TNIP1 is a corepressor of agonist-bound PPARs.Global mapping of cell type-specific open chromatin by FAIRE-seq reveals the regulatory role of the NFI family in adipocyte differentiation.Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element.

P2860

Q24295934-6C0D57E3-D184-4070-9A38-D51C3C9087F6 Q24300315-F4E10BE7-58E6-4560-902E-5DCA89B8DD6F Q24301306-D0268CAF-2B29-446B-8805-F44939DEBCFE Q24339519-93617D15-2034-4EC6-8E6C-EEC15C5F8A59 Q24607057-BC0A583E-6CA3-45D3-A85B-CC7BD85CE814 Q24625373-5DF68019-5990-4D5E-B38D-F08846B88F0D Q24630926-5A2189BB-FDF1-4A54-B147-717C4FF2B709 Q24641991-FE37CE91-A4C3-462A-A698-E254CD6FF88A Q24645118-431E3108-C3D1-4A9B-A5A9-DE7BB3AF6ABB Q24646455-8EABB876-E89E-49BF-932B-E9C06BE03566 Q24648556-3E1BA59F-455F-4314-A94D-455F5CA12F85 Q24651915-136B37DD-7809-43D0-A7E5-0D5D827236C8 Q24653031-A35191C1-0848-4F20-ADF7-0C2CDC671275 Q24653898-07997CBA-814A-480F-ADAC-775DC902C1D4 Q26825836-4D5A34AD-4CE7-49C2-B3D4-F0D9C6EF5A62 Q26996464-A4C42E6A-3132-4A5D-AF72-D966262D3253 Q27677013-FAB60690-6A01-42A6-9972-8B416D832C3A Q28272373-A6B4DDF7-FAFB-4251-A8FF-D780BAE9ED89 Q28294725-1F1FA61E-5B46-45AD-B485-17806AA0BE17 Q28480575-6C43F43A-549C-461E-82EE-1A220B546D3C Q28553888-0FE9ADAE-30EA-4890-A5C5-08EF9938CC53 Q30419997-C37EBE0C-8BF5-48EB-9379-DF8101132F7D Q33389634-72AB656A-A14B-489D-9116-439DC576E884 Q33508325-AB7DBA21-069B-4EFF-97A6-79390B6E46B5 Q33642747-609C6426-FFAA-468D-9049-970327E8584B Q33702169-212BECAE-1B7C-4380-ACFB-B294FE76C028 Q33714951-2D8C75DA-3A5F-4020-8B7A-E5A9AF916304 Q33723377-00DD422D-EF56-4C13-923C-4720D772EFC4 Q33768593-8EAAE38E-E81C-4C5D-B952-EF654DBA5A0D Q33775726-D3902A2D-3868-4669-B4D1-B37F17836665 Q33791223-A12274F6-CCC5-476A-99F4-8861FD7076F0 Q33831801-C4B0B679-9F28-456E-84C9-E5DDACC6CB23 Q33848844-B6DA6128-E960-4037-8D8F-498A9CF16538 Q33872793-92CB5D55-207B-49BA-92D4-B6856489C6E8 Q33874323-E4F6D595-1CB9-4F50-9767-D04762C1EF6A Q33939484-20D5A602-424F-4DE3-8535-8172BF4A7D75 Q34025914-00024D07-DD92-4776-AC41-33580194ADEC Q34038903-CC72E104-3598-41D5-822F-D19C54B30D01 Q34058172-384EEB1B-877B-428A-8BBE-FA4113915481 Q34122589-B8285644-28CD-48B6-ABD9-3DDFACC6A0EC

P2860

A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.

http://www.wikidata.org/entity/Q35052559

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

A cell-type-specific transcrip ...... progression in breast cancer.

@ast

A cell-type-specific transcrip ...... progression in breast cancer.

@en

type

label

A cell-type-specific transcrip ...... progression in breast cancer.

@ast

A cell-type-specific transcrip ...... progression in breast cancer.

@en

prefLabel

A cell-type-specific transcrip ...... progression in breast cancer.

@ast

A cell-type-specific transcrip ...... progression in breast cancer.

@en

P1433

Q35052559-9142D1A9-641F-408F-8265-9BEBCCE66412

P1476

Q35052559-19404F9E-71B2-4E41-8E73-3F4E3C6C55AC

P2093

Q35052559-07B0D77E-BDDF-4AEC-AA2B-D7C55ECBA64E

Q35052559-787243E3-9330-4AD3-AFAB-7ED25A9E4E39

Q35052559-BF91F2CB-2CD2-4656-8D9F-E4F0959768AA

Q35052559-EF8E41F1-69D4-4167-9BBE-2F788F70A302

P2860

Q35052559-0408CD89-F66A-4BA6-94ED-166E4E514967

Q35052559-08392565-091E-4235-A00E-85DC85D35E07

Q35052559-0E223222-FB93-4C6A-9679-E09620702461

Q35052559-20A2F5BE-FEFB-49AB-9297-EA7CCABE6AEC

Q35052559-21971C71-F0F9-4EEF-8DC4-65306DCF4F3D

Q35052559-32BB16E9-92EC-4A29-8B1F-5ACECDF00D13

Q35052559-3A5C504D-3B2B-4CA7-AA02-D9299B526EA8

Q35052559-3DAEBF6A-7FEA-4968-B896-E8CA2F19F427

Q35052559-4038057C-7F88-4422-BCE1-86434E187D12

Q35052559-404A1526-71DC-4A70-BD02-14DB3CE9349E

P304

Q35052559-DA728A5F-FF64-4961-B478-9257066278EE

P31

Q35052559-C0744264-E63E-4C87-B7AD-F7F6DD97473C

P356

Q35052559-3F1DE858-B6A0-47F4-81A9-91FF0A6A5DE4

P433

Q35052559-6355F6A9-9D11-4C84-B13F-BC7AA5825D15

P478

Q35052559-5E12F41D-0A99-46B2-9186-BB868D324AEB

P50

Q35052559-D615184F-9B7A-4FBA-9A88-3E7E464A8F0A

P577

Q35052559-FDDC74D6-CFA2-40F9-83FE-51559C4368FF

P5875

Q35052559-73003FF5-979D-43EE-BC36-C4015670E73F

P698

Q35052559-C2A39B39-A0BB-4B82-94E0-C36C9A21B34C

P932

Q35052559-8B1F2FDF-1C20-40ED-BEFB-A44BD60021FC

P356

P1433

Genes & Development

P1476

A cell-type-specific transcrip ...... progression in breast cancer.

@en

P2093

Jason S Carroll

http://www.w3.org/2001/XMLSchema#string

Jérôme Eeckhoute

http://www.w3.org/2001/XMLSchema#string

Maria I Torres-Arzayus

http://www.w3.org/2001/XMLSchema#string

Timothy R Geistlinger

http://www.w3.org/2001/XMLSchema#string

P2860

BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1)

From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response

Cyclin D1 in breast cancer pathogenesis.

A gene-expression signature as a predictor of survival in breast cancer

c-Myc-regulated microRNAs modulate E2F1 expression

Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells

Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1

About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-alpha gene (ESR1) in breast cancer

Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics

Quantification of DNaseI-sensitivity by real-time PCR: quantitative analysis of DNaseI-hypersensitivity of the mouse beta-globin LCR

P304

2513-2526

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1101/GAD.1446006

http://www.w3.org/2001/XMLSchema#string

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6812878

http://www.w3.org/2001/XMLSchema#string

P698

16980581

http://www.w3.org/2001/XMLSchema#string

P932

1578675

http://www.w3.org/2001/XMLSchema#string